WallStreetZenWallStreetZen

NASDAQ: POM
Pomdoctor Revenue

OverviewEarningsRevenue
DividendOwnership
Pomdoctor revenue was N/A for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, POM annual revenue was $46.9M, with 9.1% growth year-over-year.

POM revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when POM announces revenue.

POM Revenue History By Year

POM Yearly RevenuePOM RevenuePOM ChangePOM Revenue Growth
2024-12-31$46.93M$3.93M+9.14%
2023-12-31$43.00MN/AN/A

1 of 1

Pomdoctor Revenue FAQ

What was Pomdoctor's annual revenue growth in the past year?

As of Q4 2025, Pomdoctor's revenue has grown null year over year. Pomdoctor's revenue in the past year totaled N/A.

How much does Pomdoctor make in a year?

Pomdoctor's revenue by year for the past one years is:
  • Pomdoctor's revenue for the twelve months ending Dec 31, 2024 was $46.93 million, a 9.14% increase year over year.

What was Pomdoctor's revenue in 2024?

Pomdoctor's annual revenue for the twelve months ending Dec 31, 2024 was $46.93 million, a 9.14% increase year over year.

How much does Pomdoctor make in a day?

Based on Pomdoctor annual revenue for the past one years, POM makes an average of $128,563.68 per day.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.